NCT02161445

Brief Summary

the gold standard for the diagnostic of acute heart failure is based on clinical, biological (BNP levels) and echocardiographic findings, but still in some cases, the diagnosis is difficult and requires further investigations. BNP dosages and echocardiography are not always available in many medical centers, especially in emergency departements, and are expensive. we investigated the use of alternative methods, such as the systolic time intervals (STI), in the diagnosis of acute heart failure (AHF) in emergency departement patients consulting for dyspnea.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
530

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 2, 2012

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

May 4, 2014

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 11, 2014

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

July 1, 2020

Status Verified

June 1, 2020

Enrollment Period

5.2 years

First QC Date

May 4, 2014

Last Update Submit

June 29, 2020

Conditions

Keywords

impedancepeptevgdyspneaAHFBNP

Outcome Measures

Primary Outcomes (1)

  • PEP/EMAT values between the AHF and non AHF groups

    compare the PEP/EMAT values between the two study groups: AHF and non-AHF. the diagnosis of AHF is made based on clinical, BNP, and echocardiographic findings.

    at admission (an average of 24 hours)

Secondary Outcomes (3)

  • PEP values between the two study groups

    at admission (an average of 24 hours)

  • compare the EMAT values between the two study groups

    at admission (an average of 24 hours)

  • compare the STI diagnostic performance against BNP

    at hospital admission (an average of 24 hours)

Study Arms (2)

AHF group

patients with AHF diagnosed based on clinical, biological and echocardiographic findings. Two sub-groups of patients were identified within HF group: Patients with reduced (\<45%) LVEF (HFrEF) and those with preserved (≥45%) LVEF (HFpEF).

Device: the acoustic cardiographic parameters were calculated

non AHF group

we included patients with acute dyspnea and for whom acute heart failure was excluded

Device: the acoustic cardiographic parameters were calculated

Interventions

STIs were measured using simultaneous recording of the electrocardiogram and acoustic cardiography signals using an analogic numeric system (Biopac Systems, Goleta, CA). A3-minute acoustic cardiographic tracing for all patients was obtained and stored electronically. We measured the electromechanical activation time (EMAT) which is the time between the initial deflection of the electrocardiographic Q wave and the first phonocardiographic complex corresponding to the first heart sound (S1). The left ventricle ejection time (LVET) defined as the interval between the peak components from the S1 and S2 complexes was measured on the same cardiac cycles. All studies were performed in patients in a semi-recumbent position with head at 30 degrees position. For each patient, the acoustic cardiographic parameters were calculated from a 10-second free of artifact recording of data averaging 8 to 12 beats measurements.

AHF groupnon AHF group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients aged more than 18 years old presenting at the ED with non traumatic dyspnea.

You may qualify if:

  • non traumatic dyspnea
  • age more than 18 years old.

You may not qualify if:

  • ECG diagnostic for acute myocardial infarction or ischemic chest pain within the prior 24 hours
  • history of a heart transplant
  • pericardial effusion
  • chest wall deformity suspected of causing dyspnea
  • coma, shock,Mechanical Ventilation, vasopressor drugs
  • arrhythmia serious and sustained, pace maker severe mitral valve disease, severe pulmonary arterial hypertension
  • renal failure with creatinine \>350micromol/l

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nouira Semir

Monastir, Emergency Department Monastir, Tunisia 5000, 5000, Tunisia

Location

Related Links

MeSH Terms

Conditions

Dyspnea

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Nouira Samir, Professor

    University hospital of Monastir

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 4, 2014

First Posted

June 11, 2014

Study Start

October 2, 2012

Primary Completion

December 31, 2017

Study Completion

December 31, 2019

Last Updated

July 1, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations